Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 6.18%111.48M | 6.60%51.49M | 10.86%104.99M | 33.43%48.3M | 923.55%94.71M | 666.41%63.2M | 491.20%36.2M | 306.91%15.36M | -36.71%9.25M | -6.77%8.25M |
| Operating income | 6.18%111.48M | 6.60%51.49M | 10.86%104.99M | 33.43%48.3M | 923.55%94.71M | 666.41%63.2M | 491.20%36.2M | 306.91%15.36M | -36.71%9.25M | -6.77%8.25M |
| Cost of sales | -9.09%-100.24M | -2.27%-44.45M | -12.87%-91.89M | -62.45%-43.46M | -697.76%-81.41M | -528.46%-50.33M | -318.64%-26.76M | -143.66%-10.17M | -23.55%-10.21M | -19.52%-8.01M |
| Operating expenses | -9.09%-100.24M | -2.27%-44.45M | -12.87%-91.89M | -62.45%-43.46M | -697.76%-81.41M | -528.46%-50.33M | -318.64%-26.76M | -143.66%-10.17M | -23.55%-10.21M | -19.52%-8.01M |
| Gross profit | -14.20%11.24M | 45.54%7.04M | -1.50%13.1M | -48.77%4.84M | 1,496.85%13.3M | 5,307.98%12.87M | 3,623.88%9.44M | 1,397.00%5.19M | -114.97%-952K | -88.90%238K |
| Administrative expenses | 10.53%-16.9M | 20.25%-9.6M | -29.94%-18.89M | -81.75%-12.04M | -4.42%-14.54M | -1.02%-10.72M | 5.36%-6.62M | 31.16%-2.88M | 39.01%-13.92M | 38.42%-10.61M |
| Profit from asset sales | --23K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus | 12.35%-284K | ---- | ---324K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of investment property | 12.35%-284K | ---- | ---324K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | -204.79%-6.18M | 39.00%1.17M | -39.70%-2.03M | --841K | -103.51%-1.45M | ---- | ---- | ---- | 92.67%-713K | -74.42%132K |
| -Impairment of property, machinery and equipment | 88.18%-50K | ---- | ---423K | ---- | ---- | ---- | ---- | ---- | 99.95%-2K | ---- |
| -Other impairment is provision | -282.04%-6.13M | 39.00%1.17M | -10.54%-1.6M | --841K | -104.08%-1.45M | ---- | ---- | ---- | 83.24%-711K | -74.42%132K |
| Special items of operating profit | 8.84%-1.3M | 124.72%400K | -1,501.12%-1.43M | -33.33%178K | -102.34%-89K | -88.55%310K | -74.43%267K | -80.95%88K | 95.93%3.8M | 198.13%2.71M |
| Operating profit | -40.08%-13.4M | 83.97%-991K | -244.40%-9.56M | -300.26%-6.18M | 76.43%-2.78M | 132.63%2.46M | 150.35%3.09M | 158.18%2.4M | 51.42%-11.78M | 44.85%-7.54M |
| Financing cost | 31.40%-83K | 52.17%-33K | 49.58%-121K | 49.26%-69K | 32.01%-240K | 31.52%-189K | 29.90%-136K | 26.26%-73K | 31.19%-353K | 29.05%-276K |
| Share of profits of associates | -94.74%9K | -95.15%16K | -63.69%171K | 1,636.84%330K | 756.36%471K | --14K | --19K | --8K | 115.90%55K | ---- |
| Earning before tax | -41.59%-13.47M | 82.98%-1.01M | -273.68%-9.51M | -299.36%-5.92M | 78.92%-2.55M | 129.23%2.28M | 146.96%2.97M | 155.27%2.33M | 51.90%-12.08M | 44.42%-7.81M |
| Tax | ---89K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2K |
| After-tax profit from continuing operations | -42.53%-13.56M | 82.98%-1.01M | -273.68%-9.51M | -299.36%-5.92M | 78.92%-2.55M | 129.23%2.28M | 146.94%2.97M | 155.27%2.33M | 51.39%-12.08M | 44.40%-7.82M |
| Earning after tax | -42.53%-13.56M | 82.98%-1.01M | -273.68%-9.51M | -299.36%-5.92M | 78.92%-2.55M | 129.23%2.28M | 146.94%2.97M | 155.27%2.33M | 51.39%-12.08M | 44.40%-7.82M |
| Profit attributable to shareholders | -42.53%-13.56M | 82.98%-1.01M | -273.68%-9.51M | -299.36%-5.92M | 78.92%-2.55M | 129.23%2.28M | 146.94%2.97M | 155.27%2.33M | 51.39%-12.08M | 44.40%-7.82M |
| Basic earnings per share | -43.04%-0.0113 | 83.67%-0.0008 | -276.19%-0.0079 | -296.00%-0.0049 | 79.21%-0.0021 | 129.23%0.0019 | 147.17%0.0025 | 154.29%0.0019 | 51.21%-0.0101 | 44.44%-0.0065 |
| Diluted earnings per share | -43.04%-0.0113 | 83.67%-0.0008 | -276.19%-0.0079 | -296.00%-0.0049 | 79.21%-0.0021 | 129.23%0.0019 | 147.17%0.0025 | 154.29%0.0019 | 51.21%-0.0101 | 44.44%-0.0065 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | -- | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.